Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPAZ: Investigation Into Hypertension Induced by Pazopanib
NCT01392352Phase 2Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Apr 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in renal cell carcinoma (RCC), ovarian cancer, Cervical Cancer (CC), glioblastoma (GBM), soft tissue sarcoma (STS), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Apr 2011; status: terminated.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)ovarian cancerCervical Cancer (CC)glioblastoma (GBM)soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01392352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01392352.